These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8032293)

  • 1. Antimicrobial susceptibility testing: are we wasting our time?
    Greenwood D
    Br J Biomed Sci; 1993 Mar; 50(1):31-4. PubMed ID: 8032293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's the use of susceptibility testing?
    Greenwood D
    J Chemother; 1997 May; 9 Suppl 1():7-12. PubMed ID: 9248957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement of routine works and quality control in mycobacterial laboratory].
    Suzuki K; Higuchi T
    Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(18):392-4. PubMed ID: 12018795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the microbiology laboratory in an era of increasing antibiotic resistance.
    Thomson KS
    Postgrad Med; 2001 Feb; 109(2 Suppl):78-81. PubMed ID: 19667561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory capacity to detect antimicrobial resistance, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 48(51-52):1167-71. PubMed ID: 11266245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F; Rüsch-Gerdes S; Hoffner S;
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 2000 May; 30(5):799-808. PubMed ID: 10816150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
    MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
    J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors contributing to excessive antimicrobial prescribing.
    Ebert SC
    Pharmacotherapy; 2007 Oct; 27(10 Pt 2):126S-130S. PubMed ID: 17896905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility testing and patterns of resistance at a tertiary care center.
    Akhter J; Qutub MO; Qadri SM
    Saudi Med J; 2001 Jul; 22(7):569-76. PubMed ID: 11479635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility testing practices for Streptococcus pneumoniae: results of a proficiency testing survey of clinical laboratories.
    Edson DC; Glick T; Massey LD
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):225-30. PubMed ID: 16545934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparability of laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae from reference laboratories in Western Europe.
    Ison CA; Martin IM; Lowndes CM; Fenton KA;
    J Antimicrob Chemother; 2006 Sep; 58(3):580-6. PubMed ID: 16807252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the microbiology laboratory in diagnosing mycobacterial diseases.
    Salfinger M; Morris AJ
    Am J Clin Pathol; 1994 Apr; 101(4 Suppl 1):S6-13. PubMed ID: 8154454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.